GB0817621D0 - Antibody - Google Patents

Antibody

Info

Publication number
GB0817621D0
GB0817621D0 GB0817621A GB0817621A GB0817621D0 GB 0817621 D0 GB0817621 D0 GB 0817621D0 GB 0817621 A GB0817621 A GB 0817621A GB 0817621 A GB0817621 A GB 0817621A GB 0817621 D0 GB0817621 D0 GB 0817621D0
Authority
GB
United Kingdom
Prior art keywords
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0817621A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma SA
Original Assignee
UCB Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Pharma SA filed Critical UCB Pharma SA
Priority to GB0817621A priority Critical patent/GB0817621D0/en
Publication of GB0817621D0 publication Critical patent/GB0817621D0/en
Ceased legal-status Critical Current

Links

GB0817621A 2008-09-25 2008-09-25 Antibody Ceased GB0817621D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0817621A GB0817621D0 (en) 2008-09-25 2008-09-25 Antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0817621A GB0817621D0 (en) 2008-09-25 2008-09-25 Antibody

Publications (1)

Publication Number Publication Date
GB0817621D0 true GB0817621D0 (en) 2008-11-05

Family

ID=40019583

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0817621A Ceased GB0817621D0 (en) 2008-09-25 2008-09-25 Antibody

Country Status (1)

Country Link
GB (1) GB0817621D0 (en)

Similar Documents

Publication Publication Date Title
EP2241578A4 (en) Anti-cldn6 antibody
ZA201102119B (en) Improved antibody libraies
GB0708002D0 (en) Antibodies
HK1136970A1 (en) Penta-specific antibody
GB0821100D0 (en) Antibodies
ZA201104545B (en) Anti-siglec-15 antibody
EP2138576A4 (en) Anti-claudin-4 antibody
IL214996A0 (en) Anti-bcma antibodies
GB0920127D0 (en) Antibodies
GB0909906D0 (en) Antibodies
EP2337798A4 (en) Bsa-specific antibodies
EP2172483A4 (en) ANTI-Muc17 ANTIBODY
EP2427496A4 (en) Anti-vegf-d antibodies
IL205073A0 (en) Anti-bst2 antibody
GB0718737D0 (en) Antibodies
ZA201006099B (en) Anti-tyrp1 antibodies
GB0920324D0 (en) Antibodies
HK1170745A1 (en) Antibodies against il-17br il-17br
ZA201007976B (en) Anti-pirb antibodies
GB0818356D0 (en) Antibodies
GB2473934B (en) Anti-VEEV antibody
EP2499256A4 (en) Anti-c-mpl antibodies
EP2424892A4 (en) Dc-stamp antibodies
GB0911770D0 (en) Antibody
EP2264071A4 (en) Antibody having an immune-enhancement function

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)